Global Riluzole Tablet Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Riluzole Tablet
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Riluzole Tablet Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 With Film-coated
- 1.3.3 Without Film-coated
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Riluzole Tablet Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Pharmacy
- 1.5 Global Riluzole Tablet Market Size & Forecast
- 1.5.1 Global Riluzole Tablet Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Riluzole Tablet Sales Quantity (2019-2030)
- 1.5.3 Global Riluzole Tablet Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Riluzole Tablet Product and Services
- 2.1.4 Sanofi Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Sanofi Recent Developments/Updates
- 2.2 Mylan Pharma
- 2.2.1 Mylan Pharma Details
- 2.2.2 Mylan Pharma Major Business
- 2.2.3 Mylan Pharma Riluzole Tablet Product and Services
- 2.2.4 Mylan Pharma Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Mylan Pharma Recent Developments/Updates
- 2.3 Apotex
- 2.3.1 Apotex Details
- 2.3.2 Apotex Major Business
- 2.3.3 Apotex Riluzole Tablet Product and Services
- 2.3.4 Apotex Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Apotex Recent Developments/Updates
- 2.4 Glemark Generics
- 2.4.1 Glemark Generics Details
- 2.4.2 Glemark Generics Major Business
- 2.4.3 Glemark Generics Riluzole Tablet Product and Services
- 2.4.4 Glemark Generics Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Glemark Generics Recent Developments/Updates
- 2.5 Covis Pharma
- 2.5.1 Covis Pharma Details
- 2.5.2 Covis Pharma Major Business
- 2.5.3 Covis Pharma Riluzole Tablet Product and Services
- 2.5.4 Covis Pharma Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Covis Pharma Recent Developments/Updates
- 2.6 Sun Pharma
- 2.6.1 Sun Pharma Details
- 2.6.2 Sun Pharma Major Business
- 2.6.3 Sun Pharma Riluzole Tablet Product and Services
- 2.6.4 Sun Pharma Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Sun Pharma Recent Developments/Updates
- 2.7 Lunan Pharma
- 2.7.1 Lunan Pharma Details
- 2.7.2 Lunan Pharma Major Business
- 2.7.3 Lunan Pharma Riluzole Tablet Product and Services
- 2.7.4 Lunan Pharma Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Lunan Pharma Recent Developments/Updates
- 2.8 Italfarmaco
- 2.8.1 Italfarmaco Details
- 2.8.2 Italfarmaco Major Business
- 2.8.3 Italfarmaco Riluzole Tablet Product and Services
- 2.8.4 Italfarmaco Riluzole Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Italfarmaco Recent Developments/Updates
3 Competitive Environment: Riluzole Tablet by Manufacturer
- 3.1 Global Riluzole Tablet Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Riluzole Tablet Revenue by Manufacturer (2019-2024)
- 3.3 Global Riluzole Tablet Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Riluzole Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Riluzole Tablet Manufacturer Market Share in 2023
- 3.4.2 Top 6 Riluzole Tablet Manufacturer Market Share in 2023
- 3.5 Riluzole Tablet Market: Overall Company Footprint Analysis
- 3.5.1 Riluzole Tablet Market: Region Footprint
- 3.5.2 Riluzole Tablet Market: Company Product Type Footprint
- 3.5.3 Riluzole Tablet Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Riluzole Tablet Market Size by Region
- 4.1.1 Global Riluzole Tablet Sales Quantity by Region (2019-2030)
- 4.1.2 Global Riluzole Tablet Consumption Value by Region (2019-2030)
- 4.1.3 Global Riluzole Tablet Average Price by Region (2019-2030)
- 4.2 North America Riluzole Tablet Consumption Value (2019-2030)
- 4.3 Europe Riluzole Tablet Consumption Value (2019-2030)
- 4.4 Asia-Pacific Riluzole Tablet Consumption Value (2019-2030)
- 4.5 South America Riluzole Tablet Consumption Value (2019-2030)
- 4.6 Middle East and Africa Riluzole Tablet Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Riluzole Tablet Sales Quantity by Type (2019-2030)
- 5.2 Global Riluzole Tablet Consumption Value by Type (2019-2030)
- 5.3 Global Riluzole Tablet Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Riluzole Tablet Sales Quantity by Application (2019-2030)
- 6.2 Global Riluzole Tablet Consumption Value by Application (2019-2030)
- 6.3 Global Riluzole Tablet Average Price by Application (2019-2030)
7 North America
- 7.1 North America Riluzole Tablet Sales Quantity by Type (2019-2030)
- 7.2 North America Riluzole Tablet Sales Quantity by Application (2019-2030)
- 7.3 North America Riluzole Tablet Market Size by Country
- 7.3.1 North America Riluzole Tablet Sales Quantity by Country (2019-2030)
- 7.3.2 North America Riluzole Tablet Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Riluzole Tablet Sales Quantity by Type (2019-2030)
- 8.2 Europe Riluzole Tablet Sales Quantity by Application (2019-2030)
- 8.3 Europe Riluzole Tablet Market Size by Country
- 8.3.1 Europe Riluzole Tablet Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Riluzole Tablet Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Riluzole Tablet Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Riluzole Tablet Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Riluzole Tablet Market Size by Region
- 9.3.1 Asia-Pacific Riluzole Tablet Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Riluzole Tablet Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Riluzole Tablet Sales Quantity by Type (2019-2030)
- 10.2 South America Riluzole Tablet Sales Quantity by Application (2019-2030)
- 10.3 South America Riluzole Tablet Market Size by Country
- 10.3.1 South America Riluzole Tablet Sales Quantity by Country (2019-2030)
- 10.3.2 South America Riluzole Tablet Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Riluzole Tablet Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Riluzole Tablet Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Riluzole Tablet Market Size by Country
- 11.3.1 Middle East & Africa Riluzole Tablet Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Riluzole Tablet Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Riluzole Tablet Market Drivers
- 12.2 Riluzole Tablet Market Restraints
- 12.3 Riluzole Tablet Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Riluzole Tablet and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Riluzole Tablet
- 13.3 Riluzole Tablet Production Process
- 13.4 Riluzole Tablet Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Riluzole Tablet Typical Distributors
- 14.3 Riluzole Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Riluzole Tablet market size was valued at USD 41 million in 2023 and is forecast to a readjusted size of USD 38 million by 2030 with a CAGR of -1.2% during review period.
Riluzole (marketed as Rilutek, Teglutik and TIGLUTIK) is a drug used to treat amyotrophic lateral sclerosis.
The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.
The Global Info Research report includes an overview of the development of the Riluzole Tablet industry chain, the market status of Hospital (With Film-coated, Without Film-coated), Pharmacy (With Film-coated, Without Film-coated), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Riluzole Tablet.
Regionally, the report analyzes the Riluzole Tablet markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Riluzole Tablet market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Riluzole Tablet market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Riluzole Tablet industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Unit), revenue generated, and market share of different by Type (e.g., With Film-coated, Without Film-coated).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Riluzole Tablet market.
Regional Analysis: The report involves examining the Riluzole Tablet market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Riluzole Tablet market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Riluzole Tablet:
Company Analysis: Report covers individual Riluzole Tablet manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Riluzole Tablet This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Riluzole Tablet. It assesses the current state, advancements, and potential future developments in Riluzole Tablet areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Riluzole Tablet market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Riluzole Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
With Film-coated
Without Film-coated
Market segment by Application
Hospital
Pharmacy
Major players covered
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Italfarmaco
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riluzole Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Riluzole Tablet, with price, sales, revenue and global market share of Riluzole Tablet from 2019 to 2024.
Chapter 3, the Riluzole Tablet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riluzole Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Riluzole Tablet market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Riluzole Tablet.
Chapter 14 and 15, to describe Riluzole Tablet sales channel, distributors, customers, research findings and conclusion.